Abstract | BACKGROUND: METHODS: RESULTS: One hundred and fifty seven patients with CF were screened and 10 were identified with a plasma deficiency of alpha(1)-antichymotrypsin (plasma concentration <0.2 g/l). In a multivariate analysis these individuals had significantly less severe lung disease than those who had normal or raised levels of alpha(1)-antichymotrypsin: forced expiratory volume in one second (FEV(1)) 69.9% predicted versus 53. 2% predicted (p=0.04) and chest radiographic score of 7.2 versus 9.7 (p=0.03) for those with and without alpha(1)-antichymotrypsin deficiency, respectively. The -15 signal peptide genotype did not affect plasma levels, but the -15 Ala/Ala signal peptide genotype was over-represented in individuals with CF compared with healthy blood donor controls. CONCLUSION: These data indicate that deficiency of alpha(1)-antichymotrypsin is associated with less severe pulmonary disease in patients with CF, and support our previous observations that mild genetic deficiency of a proteinase inhibitor is associated with an improved outcome.
|
Authors | R Mahadeva, L Sharples, R I Ross-Russell, A K Webb, D Bilton, D A Lomas |
Journal | Thorax
(Thorax)
Vol. 56
Issue 1
Pg. 53-8
(Jan 2001)
ISSN: 0040-6376 [Print] England |
PMID | 11120905
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Protein Sorting Signals
- alpha 1-Antichymotrypsin
|
Topics |
- Adult
- Cystic Fibrosis
(enzymology, physiopathology)
- Female
- Forced Expiratory Volume
(physiology)
- Genotype
- Humans
- Lung Diseases
(complications, physiopathology)
- Male
- Multivariate Analysis
- Protein Sorting Signals
(genetics, physiology)
- alpha 1-Antichymotrypsin
(blood, deficiency, genetics)
|